Gilead Sciences Inc. said Monday it named Merdad Parsey its chief medical officer, effective Nov. 1. Parsey was most recently a senior vice president of early clinical development...
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more...
Which stock wins in a matchup between these two big drugmakers?
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) announced that it has started enrollment in an exploratory phase II study to evaluate defibrotide for the prevention of CAR T-cell...
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Gilead Sciences...
Gilead Sciences, Inc. (NASDAQ:GILD) and partner Galapagos NV (NASDAQ:GLPG) announced 52-week efficacy and safety results of an investigational, oral, selective JAK1 inhibitor,...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Sell||Buy||Buy||Neutral||Strong Sell|
|Technical Indicators||Sell||BUY||Strong Buy||Strong Buy||Strong Sell|
|Summary||Sell||Buy||Strong Buy||Buy||Strong Sell|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Doji Star Bearish||1D||Current|
|Dragonfly Doji||1H||2||Oct 11, 2019 01:00PM|
|Three Inside Up||1W||6||Sep 01, 2019|
|Engulfing Bearish||1M||12||Oct 18|
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.Read More
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$500||Start Trading|
|Securities Investor Protection Corporation (United States)||$0||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.